They reported solid results on a new treatment for oral mucositis prevention. The problem is that the interim results were amazing and the current results are just solid. Many people were expecting amazing final results so the stock is down. Probably a good time to enter. Lots of buying today so I think the stock will drift higher.
They have results on their psoriasis drug phase 2b trial coming in January. So more catalysts ahead.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.